V. Baillat

发表

Suppression of MicroRNA-Silencing Pathway by HIV-1 During Virus Replication

Pascal Barbry, Bernard Mari, Kuan-Teh Jeang, 2007, Science.

Spontaneous secretion of immunoglobulins and anti-HIV-1 antibodies by in vivo activated B lymphocytes from HIV-1-infected subjects: monocyte and natural killer cell requirement for in vitro terminal differentiation into plasma cells.

M. Zembala, C. Alix-Panabières, V. Baillat, 2002, Clinical immunology.

CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1.

M. Benkirane, J. Eliaou, J. Clot, 2000, The Journal of infectious diseases.

The immunological response to highly active antiretroviral therapy is linked to CD4+ T-cell surface CCR5 density.

J. Clot, V. Baillat, J. Reynes, 2006, Journal of acquired immune deficiency syndromes.

T-Cell Surface CCR5 Density Is Not Correlated With Hepatitis Severity in Hepatitis C Virus/HIV-Coinfected Individuals: Implications for the Therapeutic Use of CCR5 Antagonists

M. Vidal, J. Clot, J. Ducos, 2005, Journal of acquired immune deficiency syndromes.

Vitamin E supplementation increases the expression of the CCR5 coreceptor in HIV-1 infected subjects.

J. Clot, M. Segondy, V. Le Moing, 2004, Clinical nutrition.

Low CD4+ T-cell surface CCR5 density as a cause of resistance to in vivo HIV-1 infection.

J. Clot, V. Baillat, J. Reynes, 2003, Journal of acquired immune deficiency syndromes.

CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression

M. Picot, J. Eliaou, J. Clot, 2001, AIDS.

Reasons for Early Abacavir Discontinuation in HIV-Infected Patients

J. Fabre, V. Baillat, J. Reynes, 2003, The Annals of pharmacotherapy.

Decrease in LDL size in HIV-positive adults before and after lopinavir/ritonavir-containing regimen: an index of atherogenicity?

J. Cristol, A. Dupuy, V. Baillat, 2003, Atherosclerosis.

Lopinavir/ritonavir monotherapy versus current treatment continuation for maintenance therapy of HIV-1 infection: the KALESOLO trial.

J. Izopet, G. Chêne, S. Kolta, 2010, The Journal of antimicrobial chemotherapy.

CXCR4 Overexpression During the Course of HIV-1 Infection Correlates With the Emergence of X4 Strains

J. Clot, M. Segondy, Yea-Lih Lin, 2005, Journal of acquired immune deficiency syndromes.

Small dense LDL and atherogenic lipid profile in HIV-positive adults: influence of lopinavir/ritonavir-containing regimen.

J. Cristol, A. Dupuy, V. Baillat, 2003, AIDS.

Interferon-α restores HIV-induced alteration of natural killer cell perforin expression in vivo

J. Clot, V. Pinet, V. Baillat, 2003 .

Is tenofovir involved in hypophosphatemia and decrease of tubular phosphate reabsorption in HIV-positive adults?

J. Cristol, V. Baillat, J. Reynes, 2006, The Journal of infection.

A highly virulent variant of HIV-1 circulating in the Netherlands

Michael J. Rausch, H. Jessen, A. Trkola, 2022, Science.

Long-term persistence of memory B cells specific for hepatitis B surface antigen in HIV-1-infected patients

G. Petitjean, V. Baillat, J. Reynes, 2007, AIDS.

Close association of CD8+/CD38bright with HIV‐1 replication and complex relationship with CD4+ T‐cell count

M. Picot, M. Segondy, V. Baillat, 2009, Cytometry. Part B, Clinical cytometry.

Detection of peripheral HIV-1-specific memory B cells in patients untreated or receiving highly active antiretroviral therapy

H. Yssel, P. Van de Perre, V. Baillat, 2003, AIDS.

Dynamics of spontaneous HIV-1 specific and non-specific B-cell responses in patients receiving antiretroviral therapy

M. Segondy, C. Alix-Panabières, V. Baillat, 2002, AIDS.

Unintegrated HIV-1 provides an inducible and functional reservoir in untreated and highly active antiretroviral therapy-treated patients

G. Petitjean, M. Segondy, V. Baillat, 2007, Retrovirology.

Suv39H1 and HP1γ are responsible for chromatin‐mediated HIV‐1 transcriptional silencing and post‐integration latency

A. Knezevich, A. Marcello, M. Benkirane, 2007, The EMBO journal.

Interferon-alpha restores HIV-induced alteration of natural killer cell perforin expression in vivo.

J. Clot, V. Pinet, V. Baillat, 2003, AIDS.

Perforin expression in T cells and virological response to PEG-interferon alpha2b in HIV-1 infection

J. Clot, V. Baillat, J. Reynes, 2003, AIDS.

Relationship between CCR5 density and viral load after discontinuation of antiretroviral therapy.

J. Clot, V. Baillat, J. Reynes, 2004, JAMA.

Fenofibrate improves the atherogenic lipid profile and enhances LDL resistance to oxidation in HIV-positive adults.

J. Cristol, A. Dupuy, V. Baillat, 2004, Atherosclerosis.

Detection and Enumeration of Circulating HIV-1–Specific Memory B Cells in HIV-1–Infected Patients

V. Baillat, J. Reynes, M. Huguet, 2004, Journal of acquired immune deficiency syndromes.

Human Immunodeficiency Virus Type 1 (HIV-1) Antigen Secretion by Latently Infected Resting CD4+ T Lymphocytes from HIV-1-Infected Individuals

G. Petitjean, P. Becquart, V. Baillat, 2004, Journal of Virology.

Human Immunodeficiency Virus Type 1 ( HIV-1 ) Antigen Secretion by Latently Infected Resting CD 4 T Lymphocytes from HIV-1-Infected Individuals

G. Petitjean, P. Becquart, V. Baillat, 2004 .

Long-term persistence of memory B cells specific for hepatitis B surface antigen in HIV-1-infected patients

J. Desenclos, F. Brun-Vézinet, G. Petitjean, 2007, AIDS.

Disrupting the Pairing Between let-7 and Hmga 2 Enhances Oncogenic Transformation

K. Lebrigand, M. A. Nedbal, V. Baillat, 2022 .

Close association of CD8+/CD38bright with HIV‐1 replication and complex relationship with CD4+ T‐cell count

M. Picot, M. Segondy, V. Baillat, 2009, Cytometry. Part B, Clinical cytometry.